Cullinan Gets FDA Investigational Clearance for Leukemia Drug
Cullinan received FDA clearance to test a ''differentiated treatment approach'' for acute myeloid leukemia ''by targeting extracellular FLT3.''
Cullinan Gets FDA Investigational Clearance for Leukemia Drug
Cullinan received FDA clearance to test a ''differentiated treatment approach'' for acute myeloid leukemia ''by targeting extracellular FLT3.''